APO RESEARCH · REPORT
Octreotide
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Product & engineering
Understand the product.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Selected research
Industry Growth & Trends
Global Octreotide Industry Growth and Trends Forecast to 2032
Market perspective
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Octreotide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Octreotide market size, estimates, and forecasts are presented in terms of sales volume (Gram) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Octreotide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Octreotide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Octreotide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Octreotide Market by Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Applications
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
Companies covered
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Octreotide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Octreotide Sales Estimates and Forecasts (2021-2032)
- 1.3 Octreotide Market by Type
- 1.3.1 Octreotide Injection
- 1.3.2 Octreotide Powder
- 1.3.3 Octreotide Microspheres
- 1.4 Global Octreotide Market Size by Type
- 1.4.1 Global Octreotide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Octreotide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Octreotide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Octreotide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Octreotide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Octreotide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Octreotide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Octreotide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Octreotide Industry Trends
- 2.2 Octreotide Industry Drivers
- 2.3 Octreotide Industry Opportunities and Challenges
- 2.4 Octreotide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Octreotide Revenue (2021-2026)
- 3.2 Global Top Players by Octreotide Sales (2021-2026)
- 3.3 Global Top Players by Octreotide Price (2021-2026)
- 3.4 Global Octreotide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Octreotide Major Company Production Sites & Headquarters
- 3.6 Global Octreotide Company, Product Type & Application
- 3.7 Global Octreotide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Octreotide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Octreotide Players Market Share by Revenue in 2025
- 3.8.3 2025 Octreotide Tier 1, Tier 2, and Tier 3
4 Octreotide Regional Status and Outlook
- 4.1 Global Octreotide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Octreotide Historic Market Size by Region
- 4.2.1 Global Octreotide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Octreotide Sales in Value by Region (2021-2026)
- 4.2.3 Global Octreotide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Octreotide Forecasted Market Size by Region
- 4.3.1 Global Octreotide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Octreotide Sales in Value by Region (2027-2032)
- 4.3.3 Global Octreotide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Octreotide by Application
- 5.1 Octreotide Market by Application
- 5.1.1 Treating Severe Diarrhea
- 5.1.2 Treating Acromegaly
- 5.1.3 Others
- 5.2 Global Octreotide Market Size by Application
- 5.2.1 Global Octreotide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Octreotide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Octreotide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Octreotide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Octreotide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Octreotide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Octreotide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Octreotide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Novartis Octreotide Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Sun Pharmaceutical
- 6.2.1 Sun Pharmaceutical Company Information
- 6.2.2 Sun Pharmaceutical Business Overview
- 6.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sun Pharmaceutical Octreotide Product Portfolio
- 6.2.5 Sun Pharmaceutical Recent Developments
- 6.3 Chengdu Tiantaishan pharmaceutical
- 6.3.1 Chengdu Tiantaishan pharmaceutical Company Information
- 6.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
- 6.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
- 6.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
- 6.4 Sinopharm A-Think Pharmaceuticals
- 6.4.1 Sinopharm A-Think Pharmaceuticals Company Information
- 6.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
- 6.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
- 6.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
- 6.5 Sihuan Pharmaceutical Holdings Group
- 6.5.1 Sihuan Pharmaceutical Holdings Group Company Information
- 6.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
- 6.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
- 6.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
- 6.6 Shanghai Soho-Yiming Pharmaceuticals
- 6.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 6.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 6.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
- 6.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 6.7 Yibin Pharmaceutical
- 6.7.1 Yibin Pharmaceutical Company Information
- 6.7.2 Yibin Pharmaceutical Business Overview
- 6.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
- 6.7.5 Yibin Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Octreotide Sales by Country
- 7.1.1 North America Octreotide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Octreotide Sales by Country (2021-2026)
- 7.1.3 North America Octreotide Sales Forecast by Country (2027-2032)
- 7.2 North America Octreotide Market Size by Country
- 7.2.1 North America Octreotide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Octreotide Market Size by Country (2021-2026)
- 7.2.3 North America Octreotide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Octreotide Sales by Country
- 8.1.1 Europe Octreotide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Octreotide Sales by Country (2021-2026)
- 8.1.3 Europe Octreotide Sales Forecast by Country (2027-2032)
- 8.2 Europe Octreotide Market Size by Country
- 8.2.1 Europe Octreotide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Octreotide Market Size by Country (2021-2026)
- 8.2.3 Europe Octreotide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Octreotide Sales by Country
- 9.1.1 Asia-Pacific Octreotide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Octreotide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Octreotide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Octreotide Market Size by Country
- 9.2.1 Asia-Pacific Octreotide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Octreotide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Octreotide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Octreotide Sales by Country
- 10.1.1 South America Octreotide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Octreotide Sales by Country (2021-2026)
- 10.1.3 South America Octreotide Sales Forecast by Country (2027-2032)
- 10.2 South America Octreotide Market Size by Country
- 10.2.1 South America Octreotide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Octreotide Market Size by Country (2021-2026)
- 10.2.3 South America Octreotide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Octreotide Sales by Country
- 11.1.1 Middle East and Africa Octreotide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Octreotide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Octreotide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Octreotide Market Size by Country
- 11.2.1 Middle East and Africa Octreotide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Octreotide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Octreotide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Octreotide Value Chain Analysis
- 12.1.1 Octreotide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Octreotide Production Mode & Process
- 12.2 Octreotide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Octreotide Distributors
- 12.2.3 Octreotide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst